» Articles » PMID: 27813025

Involvement of Programmed Cell Death in Neurotoxicity of Metallic Nanoparticles: Recent Advances and Future Perspectives

Overview
Publisher Springer
Specialty Biotechnology
Date 2016 Nov 5
PMID 27813025
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The widespread application of metallic nanoparticles (NPs) or NP-based products has increased the risk of exposure to NPs in humans. The brain is an important organ that is more susceptible to exogenous stimuli. Moreover, any impairment to the brain is irreversible. Recently, several in vivo studies have found that metallic NPs can be absorbed into the animal body and then translocated into the brain, mainly through the blood-brain barrier and olfactory pathway after systemic administration. Furthermore, metallic NPs can cross the placental barrier to accumulate in the fetal brain, causing developmental neurotoxicity on exposure during pregnancy. Therefore, metallic NPs become a big threat to the brain. However, the mechanisms underlying the neurotoxicity of metallic NPs remain unclear. Programmed cell death (PCD), which is different from necrosis, is defined as active cell death and is regulated by certain genes. PCD can be mainly classified into apoptosis, autophagy, necroptosis, and pyroptosis. It is involved in brain development, neurodegenerative disorders, psychiatric disorders, and brain injury. Given the pivotal role of PCD in neurological functions, we reviewed relevant articles and tried to summarize the recent advances and future perspectives of PCD involvement in the neurotoxicity of metallic NPs, with the purpose of comprehensively understanding the neurotoxic mechanisms of NPs.

Citing Articles

Extracellular Vesicles: Therapeutic Potential in Central Nervous System Trauma by Regulating Cell Death.

Chen Y, Zhang H, Hu X, Cai W, Jiang L, Wang Y Mol Neurobiol. 2023; 60(12):6789-6813.

PMID: 37482599 DOI: 10.1007/s12035-023-03501-w.


Different Ways to Die: Cell Death Pathways and Their Association With Spinal Cord Injury.

Guha L, Singh N, Kumar H Neurospine. 2023; 20(2):430-448.

PMID: 37401061 PMC: 10323345. DOI: 10.14245/ns.2244976.488.


Recent Advances of Calcium Carbonate Nanoparticles for Biomedical Applications.

Zhao P, Tian Y, You J, Hu X, Liu Y Bioengineering (Basel). 2022; 9(11).

PMID: 36421092 PMC: 9687225. DOI: 10.3390/bioengineering9110691.


Astragaloside IV protects against ischemia/reperfusion (I/R)-induced kidney injury based on the Keap1-Nrf2/ARE signaling pathway.

Su Y, Xu J, Chen S, Feng J, Li J, Lei Z Transl Androl Urol. 2022; 11(8):1177-1188.

PMID: 36092836 PMC: 9459544. DOI: 10.21037/tau-22-505.


Computational and Experimental Assessments of Magnolol as a Neuroprotective Agent and Utilization of UiO-66(Zr) as Its Drug Delivery System.

Santos J, Quimque M, Liman R, Agbay J, Macabeo A, Corpuz M ACS Omega. 2021; 6(38):24382-24396.

PMID: 34604621 PMC: 8482410. DOI: 10.1021/acsomega.1c02555.


References
1.
Zhao Z . Oxidative stress-elicited myocardial apoptosis during reperfusion. Curr Opin Pharmacol. 2004; 4(2):159-65. DOI: 10.1016/j.coph.2003.10.010. View

2.
Dekhuijzen P . Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Eur Respir J. 2004; 23(4):629-36. DOI: 10.1183/09031936.04.00016804. View

3.
Hildeman D . Regulation of T-cell apoptosis by reactive oxygen species. Free Radic Biol Med. 2004; 36(12):1496-504. DOI: 10.1016/j.freeradbiomed.2004.03.023. View

4.
Riedl S, Shi Y . Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol. 2004; 5(11):897-907. DOI: 10.1038/nrm1496. View

5.
Klionsky D . The molecular machinery of autophagy: unanswered questions. J Cell Sci. 2004; 118(Pt 1):7-18. PMC: 1828869. DOI: 10.1242/jcs.01620. View